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Research
Persistent organic pollutants are chemicals 
with notable environmental persistence and 
the potential for long­range transport, bio­
accumulation, and toxic effects. In 2001, 
the Stockholm Convention identified 12 of 
these chemicals, including polychlorinated 
biphenyls (PCBs), polychlorinated dibenzo­p­
dioxins (PCDDs), polychlorinated dibenzo­
furans (PCDFs), and selected organochlorine 
pesticides such as dichlorodiphenyltrichloro­
ethane (DDT) (United Nations Environment 
Program 2001). Although the use and emis­
sion of these chemicals in the United States 
were discontinued or restricted in the mid­ to 
late 1970s, the general population is still being 
exposed to them at low levels, predominantly 
by the dietary route [Centers for Disease 
Control and Prevention (CDC) 2005a].
The pregnant woman’s exposure to per­
sistent organic chemicals is of much interest 
because of exposures to the fetus and breast­fed 
infant and potential subsequent health effects. 
During pregnancy, the disposition of chemicals 
can be affected by physiologic changes, such 
as increased renal perfusion, increased volume 
of distribution, and increased serum lipids. 
The 200–400% increase of serum triglycer­
ide concentration (Montes et al. 1984; Sattar 
et al. 1997) can cause the redistribution of lipo­
philic chemicals stored in adipose tissue to the 
blood compartment (Phillips et al. 1989). The 
significance of understanding the changes of 
these chemicals during gestation is to appro­
priately classify the fetus’s level of exposure 
based on the sampling period during gestation 
(Longnecker et al. 1999), and to determine 
whether there are different risks to the fetus 
based on the exposure to these chemicals dur­
ing certain gestational periods. Previous stud­
ies with pregnant females have demonstrated 
inconsistent trends of blood concentrations 
of PCBs and selected organochlorine pesti­
cides [1,1´­(2,2­dichloroethenylidene)­bis(4­
chloro  benzene) (p,p´­DDE)], trans­nonachlor, 
hexachloro  benzene, and β­hexa  cyclo  chloro­
hexane (β­HCH)] throughout the trimesters 
(Jarrell et al. 2005; Longnecker et al. 1999; 
Takser et al. 2005). Potential delays in growth 
and neuro  develop  ment in the fetus and breast­
fed infant from exposure to persistent organic 
pollutants (Jacobson and Jacobson 1996; 
Koopman­Esseboom et al. 1994; Patandin et al. 
1999; Siddiqui et al. 2003) have been studied; 
the results suggest that these health effects can 
be related to late gestational exposure, although 
these findings are inconclusive, and additional 
studies are necessary to better characterize these 
risks to the newborn. Because these chemicals 
tend to accumulate in the body over a person’s 
lifetime, women of childbearing age should 
consider their exposure to these chemicals as 
they plan their reproductive future.
First­time pregnant females are considered 
a reliable index of exposure among pregnant 
females because of the lack of potential con­
founding variables, such as parity and prior 
breast­feeding (James et al. 2002; Sarcinelli 
et al. 2003), and they have been used in inter­
national studies to monitor the entire popu­
lation’s exposure to these chemicals [World 
Health Organization (WHO) 2007]. We eval­
uated the concentrations of persistent organic 
pollutants in a sample of first­time pregnant 
females residing in the United States and the 
changes of these concentrations during gesta­
tion for all pregnant women participating in 
National Health and Nutrition Examination 
Survey (NHANES) 1999–2002.
methods
We selected participants in this study from 
NHANES (1999–2000, 2001–2002), which 
used a complex, stratified, multistage, prob­
ability sampling designed to be representative 
of the civilian, noninstitutionalized U.S. popu­
lation based on age, sex, and race/ethnicity 
(CDC 2004). We selected all females 16–59 
years of age from these two survey periods and 
categorized them as pregnant or nonpregnant 
based on a urine pregnancy test that was used 
to screen participants for exclusion from a dual­
energy X­ray absorptiometry scan. We analyzed 
the data for clinical chemistries and selected 
PCDDs, PCDFs, non­ortho­substituted or 
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oBjectives: In this study we evaluated the concentrations of selected persistent organic pollutants 
in a sample of first-time pregnant females residing in the United States and assessed differences in 
these concentrations in all pregnant females during gestation.
Me t h o d s : We reviewed demographic and laboratory data for pregnant females participating in the 
National Health and Nutrition Examination Survey, including concentrations of 25 polychlorinated 
biphenyls (PCBs), 6 polychlorinated dibenzo-p-dioxins (PCDDs), 9 polychlorinated dibenzofurans 
(PCDFs), and 9 organochlorine pesticides. We report serum concentrations for first-time pregnant 
females (2001–2002; n = 49) and evaluate these concentrations in all pregnant females by trimester 
(1999–2002; n = 203) using a cross-sectional analysis.
re s u l t s: The chemicals with ≥ 60% detection included PCBs (congeners 126, 138/158, 
153, 180), PCDDs/PCDFs [1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (1234678HpCDD), 
1,2,3,6,7,8-hexachlorodibenzo-p-dioxin (123678HxCDD), 1,2,3,4,6,7,8-heptachlorodibenzofuran 
(1234678HpCDF), 1,1´-(2,2-dichloroethenylidene)-bis(4-chlorobenzene) (p,p´-DDE)], and trans-
nonachlor. The geometric mean concentration (95% confidence intervals) for 1234678HpCDD 
was 15.9 pg/g lipid (5.0–50.6 pg/g); for 123678HxCDD, 9.7 pg/g (5.5–17.1 pg/g); and for 
1234678HpCDF, 5.4 pg/g (3.3–8.7 pg/g). The differences in concentrations of these chemicals 
by trimester were better accounted for with the use of lipid-adjusted units than with whole-
weight units; however, the increase in the third-trimester concentration was greater for PCDDs/
PCDFs (123678HxCDD, 1234678HpCDF) than for the highest concentration of indicator PCBs 
(138/158, 153, 180), even after adjusting for potential confounders.
co n c l u s i o n: The concentrations of these persistent organic pollutants in a sample of first-time preg-
nant females living in the United States suggest a decline in exposures to these chemicals since their ban 
or restricted use and emission. The redistribution of body burden for these and other persistent organic 
pollutants during pregnancy needs to be more carefully defined to improve the assessment of fetal 
exposure to them based on maternal serum concentrations. Additional studies are needed to further the 
understanding of the potential health consequences to the fetus from persistent organic pollutants.
key w o r d s : dioxin, females, organochlorine pesticides, PCB, persistent organic pollutants, 
pregnant, serum concentrations. Environ Health Perspect 117:1244–1249 (2009).  doi:10.1289/
ehp.0800105 available via http://dx.doi.org/ [Online 12 March 2009]Persistent organic pollutants in U.S. pregnant females
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coplanar PCBs, other PCBs, organochlorine 
pesticides, and selected insecticide metabolites. 
The environmental chemicals were measured 
in serum by gas chromatography/isotope­ 
dilution high­resolution mass spectrometry 
(CDC 2005b, 2005c). We calculated serum 
concentration of total lipids using the concen­
trations for triglycerides and total cholesterol 
measured by an enzymatic method: total lipids 
= (2.27 × total cholesterol) + trigly  cerides + 
62.3 mg/dL (Phillips et al. 1989).
We performed all analyses using SAS (ver­
sion 9.1; SAS Institute Inc., Cary, NC) and 
SUDAAN (RTI International, Research 
Triangle Park, NC). We adjusted geometric 
means (GMs), percentages, and their confidence 
intervals for complex survey design as suggested 
by Korn and Grubbard (1998). We determined 
the GM for a chemical when the frequency of 
detection was at least 60%. We did not report 
the 50th percentile estimate (median) when it 
was less than the maximum limit of detection 
(LOD) for this study. We fitted regression mod­
els for each chemical for all females and pregnant 
females for all 4 years of data, but for first­time 
pregnant females we used data from only the 
2001–2002 survey because of the difference 
in the LOD for these chemicals between the 
two survey periods. We used the LOD divided 
by the square root of 2 to impute a value for a 
chemical with a concentration less than LOD. 
We used SUDAAN Proc REGRESS in general 
linear models to calculate the adjusted GM. We 
used log­transformed values of each chemical 
as a dependent variable. Covariates and inde­
pendent variables used were based on exist­
ing knowledge about these chemicals and the 
study population. These variables included age 
as a continuous variable, race/ethnicity (non­
Hispanic whites, non­Hispanic blacks, Mexican 
Americans, and remaining groups), country of 
birth (United States, non­United States), num­
ber of children breast­fed for at least 1 month, 
fish and seafood consumed in the last 30 days, 
serum cotinine, body mass index (BMI), and 
parity, categorized as nulliparous (having borne 
no viable fetuses and not pregnant), primipa­
rous (bearing or having borne one viable fetus), 
and multiparous (having had two or more preg­
nancies resulting in viable fetuses). We used 
trimester as a covariate in models for pregnant 
and first­time pregnant females and defined 
it as follows: first trimester, < 4 months; sec­
ond trimester, 4–6 months; and third trimester, 
> 6 months. By analyzing the cross­sectional 
data for these females at different trimesters, 
these results would approximate those observed 
by following these females longitudinally.
Results
Study population of all participants. Table 1 
presents data for the female participants in 
this study by their age, race/ethnicity, par­
ity, pregnancy status, and stage of gestation 
by trimester. The median ages in years for all 
females in this study by parity were, for nulli­
parous, 18.0; primiparous, 26.0; and multi­
parous, 41.0 (data not shown). The minimum 
and maximum ages for first­time pregnant 
females and all pregnant females in this study 
were 16–38 and 16–50 years, respectively. 
Only one participant was 50 years of age.
The pregnant females demonstrated differ­
ences in physiologic parameters that were con­
sistent with their gestational stage by trimester, 
which supported the use of these females as a 
model for gestation. For example, we observed 
the GMs for the following variables by trimes­
ter (first, second, third): BMI (27.03 kg/m2, 
28.52 kg/m2, 31.1 kg/m2), serum triglycerides 
(102.43 mg/dL, 148.19 mg/dL, 185.38 mg/
dL), serum total lipids (593.91 mg/dL, 
701.60 mg/dL, 790.75 mg/dL), hemoglobin 
(12.88 g/dL, 11.96 g/dL, 11.91 g/dL), serum 
albumin (3.98 g/dL, 3.67 g/dL, 3.30 g/dL), 
and serum creatinine (0.53 mg/dL, 0.43 mg/
dL, 0.45 mg/dL). The apparent progressive 
increase in BMI throughout gestation is pri­
marily attributed to increases in total body 
water and adipose tissue. Increased total body 
water accounted for the dilutional effect seen 
with hemoglobin and serum albumin con­
centrations, and increased cardiac output and 
renal perfusion led to increased creatinine 
clearance. During the second and third trimes­
ters, fetal growth and the preparation for lacta­
tion caused increased lipid metabolism and 
whole­weight serum concentrations in these 
females. The serum concentrations (whole 
weight) of several of the chemicals measured 
in this study directly correlated with those 
of serum lipids; the triglycerides were better 
correlated with PCDDs/PCDFs than with 
PCBs [see Supplemental Material, Table 1 
(doi:10.1289/ehp.0800319.S1)].
When we compared whole­weight and 
lipid­adjusted concentrations of these chemi­
cals by trimesters in all pregnant females, 
the amount of change in the concentrations 
among trimesters was greater for whole­
weight units than for lipid­adjusted units [see 
Supplemental Material, Table 2 (doi:10.1289/
ehp.0800319.S1)]. For example, the range for 
the absolute difference in the GM concentra­
tions of the indicator PCBs (138/158, 153, 
180) between the trimesters were for first and 
third trimesters, whole weight, 20–33%, versus 
lipid adjusted, 3–7%; and for second and third 
trimesters, whole weight, 43–60%, versus lipid 
adjusted, 24–35%. For PCDDs/PCDFs, these 
differences were for first and third trimesters, 
whole weight, 23–90%, versus lipid adjusted, 
8–51%; and for second and third trimesters, 
whole weight, 43–87%, versus lipid adjusted, 
31–74%. These comparisons demonstrated 
that lipid adjustment accounted for the change 
in the chemical concentrations during gesta­
tion better than did the use of whole­weight 
units. Thus, we used lipid adjusted concentra­
tions in the mathematical models. 
Among the variables in the general linear 
model for all pregnant females, the concen­
trations of several of the chemicals increased 
with age, except for 1,2,3,4,6,7,8­ hepta­
chloro    dibenzofuran (1234678HpCDF) and 
β­HCH [see Supplemental Material, Table 3 
(doi:10.1289/ehp.0800319.S1)]. For BMI, 
only the PCBs were inversely related to BMI 
(Table 2), which also has been previously 
observed in pregnant females (Glynn et al. 
2007; James et al. 2002; Wolff et al. 2005). 
Among the various race/ethnicities, the 
concentrations of several chemicals, includ­
ing indicator PCBs, PCDDs/PCDFs, and 
organochlorine pesticides, were higher in non­ 
Hispanic blacks than in non­Hispanic whites 
in all females in this study (Table 3). However, 
Mexican Americans had lower indicator PCB 
concentrations (e.g., 20% lower for PCB­153 
based on adjusted GM) than did non­ 
Hispanic whites. Females of non­U.S. birth had 
lower concentrations of 1,2,3,6,7,8­hexachloro­
dibenzo­p­dioxin  (123678HxCDD), 
octachlorodibenzo­p­dioxin (OCDD), and 
1234678HpCDF and higher concentra­
tions of indicator PCBs (congeners 153, 180) 
and β­HCH than did females of U.S. birth 
(Table 3). The dietary intake of fish or shellfish 
in the last 30 days was associated with increased 
concentrations of PCB­153, PCB­169, and 
1234678HpCDF [see Supplemental Material, 
Table 6 (doi:10.1289/ehp.0800319.S1)].
First-time pregnant females. Table 4 lists 
the chemicals that were detected in at least 
Table 1. Unweighted sample sizes (no.) for preg-
nant and nonpregnant females in this study by age, 
race/ethnicity, parity, and gestational trimester.
     All  First-time
  All  pregnant  pregnant
Characteristic  females  females  females
Total  1,584  203  49
Age (years)
  16–19  534  21  7
  20–29  326  122  31
  30–59  724  60  11
Race/ethnicity
  Non-Hispanic white  611  92  26
  Non-Hispanic black  352  30  5
  Mexican American  462  54  13
  Remaining groups  159  27  5
Parity
  Nulliparous  705  —  —
  Primiparous  337  155  49
  Multiparous  542  48  —
Trimester
  First    78  26
  Second    57  15
  Third    68  8
Data are for all females (16–59 years of age) who had a 
urine pregnancy test in NHANES 1999–2000 and 2001–
2002, all pregnant females based on a urine pregnancy 
test in NHANES 1999–2000 and 2001–2002, and first-time 
pregnant females based on a urine pregnancy test in 
NHANES 2001–2002.Wang et al.
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10% of the first­time pregnant females sam­
pled in 2001–2002. We determined the GMs 
or medians of the serum concentrations of 
four PCBs, three PCDDs/PCDFs, and two 
organochlorine pesticides, metabolites, or deg­
radates; these chemicals consisted of hexa­ and 
heptachlorinated PCBs and PCDDs/PCDFs, 
p,p´­DDE, and trans­nonachlor. For DDT, 
the parent chemical p,p´­DDT and its envi­
ronmental degradate, p,p´­DDE, were detected 
in 12.8% and 100% of these females, respec­
tively. The commonly detected (> 50%) 
PCDDs/PCDFs were 123678HxCDD (80%), 
1,2,3,4,6,7,8­heptachlorodibenzo­p­dioxin 
(1234678HpCDD; 100%), 1234678HpCDF 
(90%), and OCDD (51.5%).
The PCBs detected in > 10% of this group 
of females ranged in order of chlorination from 
tetrachlorinated to heptachlorinated biphenyl 
homologs, and this distribution is consistent 
with the major congeners found in Aroclor 
mixtures (e.g., 1254 and 1260) that were 
widely used in the United States in the mid­
1970s. The ranges of the frequency of detection 
and GMs of the indicator PCBs (congeners 
138/158, 153, 180) were 77–89% and 6.4–9.8 
ng/g lipid adjusted, respectively (Table 4). The 
intercorrelations between these indicator PCBs 
based on lipid­adjusted concentrations in these 
females were as follows: PCBs 138/158:153, 
r = 0.99, p < 0.0001; PCBs 153:180, r = 0.99, 
p < 0.0001; and PCBs 180:138, r = 0.97, 
p < 0.0001 (data not shown). PCB­153 has 
been used as a general indicator for the expo­
sure to non­dioxin­like PCBs and a reported 
correlation of 0.90 to total PCBs (Grimvall 
et al. 1997). The remaining non­dioxin­like 
PCBs measured in this study had a frequency of 
detection that ranged from 11.3% for PCB­187 
to 34.9% for PCB­52 (Table 4). The detection 
frequencies for coplanar PCBs (congeners 126 
and 169) and mono­ortho chlorinated PCBs 
(congeners 74 and 118) were about 50%, 
except for PCB­126, which was 93%.
Trimesters and parity. The general pat­
tern of the concentrations of several of these 
chemicals by trimesters was that they essentially 
remained unchanged during the first two tri­
mesters and then increased from the second 
to the third trimester in the adjusted model 
(Table 2). The increase in the concentration of 
these chemicals during the last trimester was sta­
tistically significant for the PCDDs/PCDFs, but 
not for the indicator PCBs. When we adjusted 
for BMI and other potential confounding vari­
ables in the comparison of these concentrations 
among trimesters, the differences between the 
last two trimesters based on the adjusted GMs 
for 123678HxCDD and 1234678HpCDF 
were 52% and 30% (p < 0.05), respectively 
(Table 2). However, we observed essentially no 
differences for the indicator PCB concentrations 
(1–11%, p > 0.05) among these trimesters.
We evaluated parity in all pregnant females 
and the concentrations of several chemicals, 
including indicator PCBs (congeners 138/158, 
153, 180), OCDD, and 1234678HpCDF, 
were lower in multiparous females than in prim­
iparous females (Table 2). In the model includ­
ing all females, nulliparous females had higher 
concentrations of p,p´­DDE and PCB­180 than 
did primiparous or multiparous females, and an 
increase in the number of children breast­fed 
for at least 1 month was associated with a lower 
concentration of   indicator PCBs (Table 5).
Table 2. Adjusted GM (95% confidence interval) for concentrations (lipid adjusted) of persistent organic pollutants by parity and trimester and regression coefficients 
for BMI for all pregnant females in this study, identified from NHANES 1999–2000 and 2001–2002.
  Parity      Trimester    BMI
Chemical  Primiparous  Multiparous  First  Second  Third  β (SE)
PCB-126 (pg/g)  11.7 (9.1–14.9)  7.5 (3.9–14.5)  9.3 (6.4–13.6)  10.5 (7.4–15.0)  12.0 (7.8–18.7)  –0.001 (0.007)
PCB-138/158 (ng/g)  11.2 (9.8–12.8)  6.1 (4.5–8.3)**  9.7 (8.5–11.1)  9.0 (7.7–10.6)  9.8 (8.0–12.0)  –0.008 (0.004)*
PCB-153 (ng/g)  14.7 (12.4–17.5)  7.6 (5.3–10.7)**  12.1 (10.5–13.9)  11.8 (10.0–13.9)  13.1 (10.4–16.5)  –0.011 (0.004)*
PCB-169 (pg/g)  6.6 (5.6–7.8)  4.2 (2.7–6.6)  5.8 (4.5–7.3)  4.9 (3.8–6.3)  7.0 (5.8–8.5)#  –0.013 (0.005)*
PCB-180 (ng/g)  8.3 (7.1–9.8)  4.5 (3.3–6.0)**  7.1 (6.0–8.4)  6.9 (5.9–8.0)  7.0 (5.6–8.7)  –0.01 (0.004)*
123678HxCDD (pg/g)  10.8 (8.7–13.4)  7.6 (5.1–11.3)  8.9 (7.2–11.0)  8.1 (6.3–10.4)  13.4 (9.9–18.3)#  0.008 (0.005)
1234678HpCDD (pg/g)  31.7 (24.4–41.2)  21.4 (15.7–29.1)  31.9 (24.7–41.1)  23.4 (17.9–30.5)  28.5 (19.2–42.2)  0.008 (0.005)
12346789OCDD (pg/g)  274.4 (219.7–342.7)  129.3 (93.5–178.6)**  217.5 (159.8–296.0)  208.3 (173.1–250.7)  252.7 (180.1–354.5)  0.004 (0.004)
1234678HpCDF (pg/g)  8.1 (6.8–9.7)  3.8 (2.7–5.4)**  6.2 (5.1–7.6)  5.9 (4.8–7.2)  8.1 (6.6–9.9)#  0.006 (0.005)
β-HCH (ng/g)  4.6 (3.7–5.9)  6.2 (2.1–18.5)  5.2 (3.8–7.2)  6.6 (3.6–12.0)  3.7 (2.9–4.7)  0.007 (0.006)
p,p´-DDE (ng/g)  141.6 (115.0–174.4)  135.9 (66.4–278.2)  117.6 (82.4–168.0)  163.1 (110.7–240.2)  159.1 (128.5–196.8)  –0.013 (0.005)
trans-Nonachlor (ng/g)  8.9 (7.7–10.4)  7.5 (4.9–11.4)  8.1 (6.8–9.8)  7.9 (6.4–9.7)  9.9 (7.7–12.8)  –0.013 (0.004)
Sample size varied from 147 to 179, depending on the chemical. The model was adjusted for parity, trimester, age, BMI, race/ethnicity, U.S. birth, fish and shellfish eaten in the last 30 
days, number of children breast-fed ≥ 1 month, and serum cotinine as independent variables. Log of serum concentration (lipid adjusted) of the chemical was the dependent variable. 
Remaining data for the model are provided in Supplemental Material, Tables 3–5 (doi:10.1289/ehp.0800319.S1).
*Statistically significantly different from 0 at α = 0.05. **Statistically significantly different from primiparous females at α = 0.05. #Statistically significantly different from second trimester 
at α = 0.05. 
Table 3. Adjusted GM (95% confidence interval) for concentrations (lipid adjusted) of persistent organic pollutants by race/ethnicity and country of birth for all 
females in this study, identified from NHANES 1999–2000 and 2001–2002.
  Race/ethnicity  Country of birth
Chemical  Non-Hispanic white  Non-Hispanic black  Mexican American  United States  Non-United States 
PCB-126 (pg/g)  13.9 (12.4–15.6)  20.3 (16.9–24.5)*  15.9 (14.2–17.7)  19.5 (17.2–22.2)  13.6 (12–15.4)
PCB-138/158 (ng/g)  16.2 (15.1–17.3)  21.7 (19.4–24.2)*  13.9 (12.6–15.4)*  15.7 (14.1–17. 4)  17.4 (16.2–18.6)
PCB-153 (ng/g)  22.8 (21.5–24.2)  30.5 (28–33.2)*  18.2 (16.5–20)*  20.8 (19–22.9)  25.1 (23.5–26.7)**
PCB-169 (pg/g)  10.9 (9.9–12)  13.4 (12.1–14.9)*  9.4 (8.7–10.2)*  11.8 (10.7–12.9)  10.8 (9.8–11.9)
PCB-180 (ng/g)  14.1 (13.2–15)  17.2 (16.1–18.4)*  12.3 (11.5–13.2)*  13.9 (13.1–14.8)  14.5 (13.4–15.7)**
1234678HpCDD (pg/g)  30.9 (27.8–34.2)  44.2 (39.2–49.8)*  39.3 (35.3–43.9)*  34.5 (30–39.7)  31.9 (29–35.1)
123678HxCDD (pg/g)  14.1 (12.4–16)  20.4 (16.3–25.4)*  16.3 (14.7–18.2)  27.7 (24.7–31.1)  10.9 (9.3–12.8)**
1234678HpCDF (pg/g)  6.6 (5.9–7.3)  9.8 (8.7–11.1)*  6.7 (6.1–7.5)  9.5 (8.4–10.7)  5.8 (5.2–6.6)**
12346789OCDD (pg/g)  260 (235.3–287.3)  372 (333.2–415.2)*  324.2 (295.7–355.6)*  350.7 (310.7–395.7)  245.7 (221.4–272.7)**
β-HCH (ng/g)  6.7 (6.2–7.2)  7.3 (6.5–8.3)  19 (16–22.5)*  6.7 (6–7.5)  8.7 (8–9.6)**
p,p´-DDE (ng/g)  177.2 (156.7–200.3)  311.6 (253.2–383.4)*  806.8 (674.6–964.8)*  234.3 (204.8–268)  239.4 (213.1–268.9)
trans-Nonachlor (ng/g)  13.9 (12.7–15.2)  18.2 (16–20.8)*  14.8 (13.2–16.7)  13.9 (12.6–15.3)  15 (13.6–16.5)
Sample size varied from 779 to 1,088, depending on the chemical. The model was adjusted for parity, trimester, pregnancy status, age, BMI, race/ethnicity, country of birth, fish and 
shellfish eaten in the last 30 days, number of children breast-fed ≥ 1 month, and serum cotinine as independent variables. Log of serum concentration (lipid adjusted) chemical was the 
independent variable. Remaining data for the model are provided in Supplemental Material, Tables 6 and 7 (doi:10.1289/ehp.0800319.S1).
*Statistically significantly different from non-Hispanic whites at α = 0.05. **Statistically significantly different from those born in the United States at α = 0.05.Persistent organic pollutants in U.S. pregnant females
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Discussion
This convenience sample of first­time preg­
nant females living in the United Sates in 
2001–2002 includes the initial report of 
PCDDs/PCDFs in these females.
Exposure levels. Overall, the concentra­
tions of these chemicals in this study suggest 
a decline in the exposure to persistent organic 
pollutants in pregnant females residing in the 
United States since their ban or restricted use 
and emission in the late 1970s, which is con­
sistent with the observed trend for the gen­
eral population in previous reports (Patterson 
et al. 1994; CDC 2005a). More specifically, 
the concentrations of the indicator PCBs (con­
geners 138/150, 153, and 180) in first­time 
pregnant females in this study are lower than 
those reported for pregnant females who par­
ticipated in the Collaborative Perinatal Project 
from 1959 through 1966 (Niswander and 
Gordoni 1972). In an approximately a one­
third subset of first­time pregnant females, their 
median serum concentrations of PCB­153 was 
140 ng/g lipid adjusted (Daniels et al. 2003) 
(vs. 8.0 ng/g lipid adjusted for this study) and 
for p,p´­DDE was 25 ng/mL whole weight 
(Longnecker et al. 2001) (vs. 113.0 ng/g lipid 
adjusted for this study). The rate of decline in 
the PCB­153 concentration from 1959–1966 
to 1999–2002 appears to be consistent with the 
estimated half­life of approximately 10 years 
for these chemicals (Yakushij et al. 1984). The 
concentrations of PCDDs/PCDFs in adipose 
tissue were reported for females in the National 
Human Adipose Tissue Survey from 1986 to 
mid­1990 (Orban et al. 1994; Reynolds et al. 
2005) and comparative data on these chemicals 
suggest a more gradual rate of decline than for 
the PCBs.
Human milk concentrations of these chem­
icals were measured in two pooled collections 
obtained from first­time mothers in the United 
States in 2002–2003 as part of the third round 
of the WHO­coordinated exposure study on 
the levels of PCBs, PCDDs, and PCDFs in 
human milk (PCB­153, 15.9 and 24.2 ng/g 
lipid; 1234678HpCDD, 16.0 and 12.9 pg/g 
lipid; 1234678HpCDF, 3.1 and 1.5 pg/g lipid; 
p,p´­DDE, 248 and 123 ng/g lipid) (Wang 
and Needham 2003, 2004). These concentra­
tions are comparable to those for the first­time 
pregnant females in this study and lower than 
those measured in two pooled milk samples 
from U.S. women participating in a similar 
WHO survey conducted in 1989 (PCB­153, 
80 and 88 ng/g lipid; 1234678HpCDD, 34 
and 50 pg/g lipid; 1234678HpCDF, 2.4 and 
5.7 pg/g lipid) (Yrjanheikki 1989). The direct 
comparison of concentrations of higher order 
chlorinated PCDDs/PCDFs of serum to milk 
specimens is limited by the diminished abil­
ity of these chemicals to transfer from blood 
to milk due to size exclusion (Wittsiepe et al. 
Table 4. Serum concentrations for persistent organic pollutants measured in first-time pregnant females in 
this study, identified from NHANES 2001–2002.
  Maximum   Percent    GMs (95% CI)  Median (95% CI)
  LOD  below LOD  Whole weight  Lipid adjusted  Lipid adjusted
Non-dioxin-like PCBs (ng/g) 
  PCB-52  11.5  65.1  NC  NC  NC
  PCB-99  7.6  80.1  NC  NC  NC
  PCB-138/158  7.6  23.3  0.06 (0.04–0.07)  8.4 (6.2–11.3)  NC
  PCB-153  7.6  19.8  0.06 (0.05–0.08)  9.8 (7.2–13.4)  8.0 (5.2–17.8)
  PCB-170  7.6  71.8  NC  NC  NC
  PCB-180  7.6  35  0.04 (0.03–0.06)  6.4 (4.5–9.2)  NC
  PCB-187  7.6  88.7  NC  NC  NC
Coplanar PCBs (fg/g for whole weight, pg/g for lipid adjusted)
  PCB-126  9.2  7.3  101.5 (56.0–183.9)  15.7 (7.4–33.5)  11.2 (3.2–211.0)
  PCB-169  7.2  53.1  NC  NC  NC
Mono-ortho-substituted PCBs (ng/g) 
  PCB-74  7.6  50  NC  NC  NC
  PCB-118  7.6  65.3  NC  NC  NC
PCDDs (fg/g for whole weight, pg/g for lipid adjusted)
  1234678HpCDD  —  0  104.4 (36.6–298.0)  15.9 (5.0–50.6)  12.4 (5.4–59.6)
  123678HxCDD  6.4  19.7  64.0 (34.3–119.3)  9.7 (5.5–17.1)  NC
  12346789OCDD  180  48.5  NC  NC  NC
PCDFs (fg/g for whole weight, pg/g for lipid adjusted)
  1234678HpCDF  3.7  10  35.2 (23.8–52.1)  5.4 (3.3–8.7)  4.3 (2.4–14.4)
  123478HxCDF  4.2  58.1  NC  NC  NC
  123678HxCDF  4.1  77.7  NC  NC  NC
  23478PeCDF  5.5  71.2  NC  NC  NC
Organochlorine insecticides (ng/g)
  p,p´-DDE  —  0  1.2 (0.6–2.7)  186.2 (75.1–461.2)  113.0 (93.7–269.0)
  p,p´-DDT  12.6  87.2  NC  NC  NC
  Heptachlor epoxide  7.6  88.5  NC  NC  NC
  β-HCH  7.6  73.8  NC  NC  NC
  Oxychlordane  7.6  67.7  NC  NC  NC
  trans-Nonachlor  5.9  23.1  0.05 (0.04–0.06)  7.4 (5.9–9.3)  7.4 (3.5–7.4)
Sample size varied from 23 to 39, depending on the chemical. Estimates were not calculated (NC) when either the proportion 
of results below the LOD was too high to provide a valid result or the estimate of the percentile was below the maximum LOD. 
Table 5. Adjusted GM (95% confidence interval) for concentrations (lipid adjusted) of persistent organic pollutants and regression coefficient for number of 
breast-fed children for at least 1 month, parity, and pregnancy status for all females in this study, identified from NHANES 1999–2000 and 2001–2002.
  No. of
  children breast-fed  Parity  Pregnant
Chemical   ≥ 1 month β (SE)  Nulliparous  Primiparous  Multiparous  Yes  No
PCB-126  0.0045 (0.019)  16.7 (13.7–20.5)  16.6 (13.4–20.6)  14.6 (11.7–18.1)  12 (8.3–17.3)  15.9 (14.5–17.3)
PCB-138/158  –0.025 (0.012)##  17.4 (15.3–19.9)  17.1 (15.1–19.5)  15.8 (14–17.9)  13.3 (11.4–15.5)  16.8 (15.8–18)#
PCB-153  –0.026 (0.011)##  24.9 (22.4–27.6)  24.3 (21.6–27.3)  21.5 (19.4–23.9)  18.5 (15.8–21.6)  23.4 (22.1–24.9)#
PCB-169  –0.0155 (0.017)  11.5 (10–13.2)  11.8 (10.4–13.3)  10.7 (9.3–12.4)  8.3 (6.7–10.10)  11.4 (10.6–12.2)#
PCB-180  0.040 (0.011)##  15.8 (14.3–17.5)  14.9 (13.1–17)  12.9 (11.8–14.2)**  11.6 (10.2–13.3)  14.4 (13.6–15.2)#
1234678HpCDD  0.0036 (0.014)  32 (27.7–37)  33.7 (29.3–38.9)  33 (28.7–37.9)  29.1 (23.4–36.2)  33.1 (30.6–35.8)
123678HxCDD  –0.0287 (0.024)  11.5 (9.4–14.1)  15.3 (12.4–18.9)**  18.5 (15.3–22.2)**  11.7 (9.3–14.7)  15.8 (14.1–17.8)#
1234678HpCDF  0.0030 (0.012)  7.1 (6.2–8.2)  6.9 (5.9–8.1)  7.1 (6.1–8.2)  6.7 (5.4–8.3)  7.1 (6.5–7.7)
12346789OCDD  0.00017 (0.0.14)  272.2 (235–315.2)  263.7 (229.1–303.4)  291.8 (252.6–336.9)  278.5 (224.9–344.9)  280.2 (258.5–303.8)
β-HCH  –0.0155 (0.017)  8 (6.8–9.6)  7.3 (6.3–8.4)  7.8 (6.8–8.9)  7.3 (5–10.7)  7.8 (7.3–8.4)
p,p´DDE  –0.0152 (0.021)  280.6 (229.8–342.6)  214.3 (187.6–244.7)**  220.9 (192.5–253.6)  228.3 (172–303.1)  237.7 (217.6–259.7)
trans-Nonachlor  –0.0317 (0.016)  15 (13.2–17.1)  14.4 (12.8–16.1)  14.2 (12.6–16.1)  13.1 (11.3–15.2)  14.6 (13.6–15.6)
Sample size varied from 779 to 1,088, depending on the chemical. The model was adjusted for parity, trimester, pregnancy status, age, BMI, race/ethnicity, country of birth, fish and 
shellfish eaten in the last 30 days, number of children breast-fed ≥ 1 month, and serum cotinine as independent variables. Log of serum concentration (lipid adjusted) chemical was the 
independent variable. Remaining data for the model are provided in Supplemental Material, Tables 6 and 7 (doi:10.1289/ehp.0800319.S1).
**Statistically significantly different than nulliparous females at α = 0.05. #Statistically significantly different than pregnant females at α = 0.05. ##Statistically significantly different than 0 
at α = 0.05.Wang et al.
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2007). Thus, these findings support the use of 
first­time pregnant females and human milk 
as a matrix to monitor the population’s trend 
in exposure to persistent lipophilic chemicals, 
although the exposure level only reflects that of 
females of reproductive age (Wang et al. 2005). 
The added benefit of using milk as an exposure 
matrix includes the ability to assess the breast­
fed infant’s intake of these chemicals.
Maternal parity, age, BMI, prior breast­
feeding, and dietary intake of fish and shellfish 
are predictors for the serum concentrations of 
these chemicals, and differences in exposure 
levels exist among race/ethnicities. Differences 
in the concentrations of PCBs among groups 
in this study are likely attributable to varia­
tions in the dietary intake of fatty foods and the 
exposure to different PCB mixtures, such as the 
Aroclor mixtures (1260, 1254, 1248), which 
were produced and used in the United States. 
Environmental degradation and biologic metab­
olism of higher to lower chlorinated homologs 
can account for differences in PCB concentra­
tions (e.g., PCB­169) in the population as well. 
In North America, the historic difference in the 
production and use of PCBs and DDT between 
Mexico and the United States may account for 
variations in the concentrations of these chemi­
cal in these populations. For example, Mexico 
imported but did not produce PCBs and was 
until recently using DDT to control vectors for 
malaria (Chanon et al. 2003). These practices 
are unlike those for the United States and may 
account for the low indicator PCB concen­
trations and high p,p´­DDE concentration in 
the Mexican Americans in this study. Other 
studies have demonstrated a difference in the 
concentrations of PCBs and p,p´­DDE in preg­
nant females (Bradman et al. 2007; James et al. 
2002; Wolff et al. 2005) and in other groups in 
the population (Finklea et al. 1972; Rogan et al. 
1986) based on race/ethnicity in the United 
States. The higher p,p´­DDE concentration 
in Mexican Americans than other race/ethnic 
groups in this study is similar to the findings 
in NHANES (2001–2002) (CDC 2005a) and 
Hispanic Health and Nutrition Examination 
Survey (1982–1984) (Akkina et al. 2004).
The increased concentrations of PCBs (con­
geners 153 and 169) and 1234678HpCDF in 
females who consumed a fish or a shellfish meal 
in the last 30 days of the survey in this study are 
consistent with prior reports demonstrating that 
these food groups can be a source of exposure to 
these chemicals in pregnant females and other 
groups in the population from regions known 
for their increased dietary intake of seafood, 
such as the Nordic countries and their territo­
ries (Glynn et al. 2007; Johansen et al. 1996) 
and the U.S. Great Lakes (Turyk et al. 2006). 
The increased consumption of crustaceans from 
contaminated waterways has been associated 
with a higher toxic equivalency concentration 
for PCDFs than for PCDDs, and the sum of 
these concentrations was higher than that for 
dioxin­like PCBs (Johansen et al. 1996).
Trimesters. The serum whole­weight con­
centrations of these chemicals are higher in the 
third trimester than in earlier trimesters, and 
this is attributed to the progressive increase in 
maternal serum nonpolar lipids, such as tri­
glycerides and cholesterol esters, that occurs 
throughout the latter two­thirds of gestation 
and is primarily for milk production (Sattar 
et al. 1997). The apparent differences in serum 
concentrations of these chemicals among the 
trimesters in this study are consistent with the 
physiologic changes during gestation, which 
include the body’s increasing volume of dis­
tribution and serum lipid concentrations. 
Increased body weight and BMI have been asso­
ciated with decreased concentrations of PCBs 
and selected organochlorine pesticides during 
gestation (Glynn et al. 2007; James et al. 2002; 
Wolff et al. 2005). For example, Glynn et al. 
(2007) reported a decrease in the concentrations 
of PCBs and selected organochlorine pesticides 
of 16–38% per unit of body weight during ges­
tation. These changes are likely explanations for 
the apparent decrease in the lipid­adjusted con­
centrations for PCBs (congeners 169 and 180) 
and PCDDs (1234678HpCDD) during the 
second trimester among all pregnant females in 
this study [see Supplemental Material, Table 2 
(doi:10.1289/ehp.0800319.S1)].
The nearly complete correction of the 
difference in the concentrations of the indi­
cator PCBs between the first and the third tri­
mester in this study by using lipid­adjusted 
units suggests that the increase in the serum 
PCB concentration reflects the redistribution 
of PCB from tissue stores (Gallenberg et al. 
1987; Phillips et al. 1989 ). This observation 
has been demonstrated for serum total PCB 
concentrations in a longitudinal study of 67 
pregnant females throughout their pregnancy 
(Longnecker et al. 1999). These changes in 
PCB concentrations among trimesters are pre­
sumed small because other studies of pregnant 
females have demonstrated a lack of statistically 
significant difference between these concentra­
tions (Jarrell et al. 2005; Takser et al. 2005).
Compared with the indicator PCBs 
(congeners 138/158, 153, and 180), the 
increases in PCDD/PCDF (123678HxCDD, 
1234678HpCDF) concentrations during the 
third trimester were greater, even after adjusting 
for serum total lipids and potential confounders 
in this study. These findings, in conjunction 
with the variation in correlations to serum lip­
ids for these chemicals, suggest there is a differ­
ence in the interaction between these classes of 
chemicals and lipoproteins based on their lipid 
content that can be related to the gestational 
change in the serum lipid profile (Sattar et al. 
1997). The increase in serum concentrations of 
nonpolar lipids can cause a greater redistribution 
of PCDDs/PCDFs than PCBs based on the 
difference in their dissolution in lipids over the 
duration of the gestation. The preferential affin­
ity to triglyceride­rich lipoproteins, such as very 
low­density lipoprotein (VLDL), by PCDDs/
PCDFs (Arehart et al. 2004; Marinovich et al. 
1983) and PCBs (Gallenberg et al. 1987) has 
been demonstrated in various settings. In an 
in vitro model, tetrachlorodibenzo­p­dioxin 
(TCDD) had a greater affinity to VLDL and 
low­density lipoprotein (LDL) than did PCBs 
(congeners 105 and 126) (Arehart et al. 2004), 
which would be consistent with the differ­
ence in correlations with triglyceride between 
PCDDs/PCDFs and PCBs [see Supplemental 
Material, Table 1 (doi:10.1289/ehp.0800319.
S1)]. Further investigations are needed to better 
characterize the contributions of lipid solubil­
ity (Sandermann 2003), protein binding (e.g., 
apolipoprotein) (Arehart et al. 2004; Patterson 
et al. 1989), and molecular rigidity to the dif­
ferences in gestational trend between PCDDs/
PCDFs and PCBs observed in this study.
Parity. The apparent decrease in concentra­
tions of the persistent organic pollutants with 
increased parity may be attributed to the depu­
ration of these chemicals from successive breast­
feedings (López­Carrillo et al. 2001; Sarcinelli 
et al. 2003) because the amount of these chemi­
cals eliminated by the transplacental route is 
presumed to be less than the amount loss by 
lactation (Jacobson and Jacobson 1996), which 
is consistent with the associations between prior 
breast­feeding and lower indicator PCB concen­
trations in this study (Table 5). However, the 
contribution to lower concentrations of these 
chemicals in females from their deposition in 
placental tissue or fetal tissues and organs cannot 
be excluded because parity remained a predic­
tive variable for certain chemicals after adjusting 
for breast­feeding. The small changes in serum 
concentrations for certain PCDDs/PCDFs (e.g., 
1234678HpCDF, 12346789OCDD) associ­
ated with prior breast­feeding among all females 
in this study might be attributable to the poor 
diffusion of these chemicals across the milk–
blood barrier (Wittsiepe et al. 2007). These 
effects of breast­feeding and parity on the chemi­
cal concentrations support the use of first­time 
pregnant females as a reliable index of exposure 
to these chemicals among pregnant females.
Limitations. The findings in this study 
are limited by the cross­sectional design, use 
of self­reported data for reproductive history, 
and small sample size. NHANES is designed to 
achieve representative concentrations of these 
environmental chemicals in the general U.S. 
population by age, sex, and race/ethnicity. Thus, 
the estimates of the central tendencies for these 
chemicals in first­time pregnant females in this 
study are likely to be unstable and not repre­
sentative of this group in the general population 
because the statistical weighting factor used in 
this analysis was not designed for these females. 
Also, the observed gestational trends for these Persistent organic pollutants in U.S. pregnant females
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chemical concentrations need to be verified in 
a prospective observational study because their 
prepregnancy values might have biased the find­
ings despite the use of statistical adjustments for 
potential confounders. Finally, the statistical 
power of the analyses to identify significant 
findings might have been limited because of 
the sample sizes, which could not be controlled 
because of the nature of the study design.
Conclusions
The findings from this study suggest a decline 
in the exposure to these persistent organic pol­
lutants in pregnant females in the United States 
since their ban or restricted use and emission, 
which is consistent with the exposure trend 
for these chemicals in the general population 
based on past reports. The redistribution of the 
body burden for persistent organic pollutants 
in response to the change in serum lipid profile 
during gestation needs to be more carefully 
defined because the concentrations of some of 
these chemicals can vary on a whole­weight 
or lipid­adjusted basis during this period. The 
sampling of blood from pregnant females at 
a specified time during gestation and the use 
of lipid­adjusted units can minimize these dif­
ferences and improve the interpretation of 
the fetus’s level of exposure to these chemi­
cals based on maternal serum concentrations. 
Additional studies on the exposure and disposi­
tion of these and other persistent organic pol­
lutants in pregnant females are needed to better 
understand the potential health consequences 
to the fetus from these exposures.
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